Sigma Healthcare Price Target Cut 7.7% to A$1.20/Share by Jefferies
Sigma Healthcare Price Target Cut 7.7% to A$1.20/Share by Jefferies
Boral to Exit S&P/ASX 200 Index Following Takeover Bid
Construction materials company Boral (ASX:BLD) will be removed from the S&P/ASX 200 index, according to a Thursday filing with the Australian Securities Exchange. This delisting follows the approval b
Analysts Offer Insights on Healthcare Companies: Novartis AG (NOVN) and Sigma Healthcare Ltd (Frankfurt: DE:S5YA)
Sigma Healthcare Downgraded to Sell From Hold by Shaw & Partners
Sigma Healthcare Downgraded to Sell From Hold by Shaw & Partners
Sigma Healthcare Price Target Raised 11% to A$1.00/Share by Shaw & Partners
Sigma Healthcare Price Target Raised 11% to A$1.00/Share by Shaw & Partners
Why Arafura, Pentanet, Sigma, and Webjet Shares Are Falling Today
The S&P/ASX 200 Index (ASX: XJO) is out of form on Friday and on track to end the week in the red. In afternoon trade, the benchmark index is down 0.3% to 7,759.9 points.
Sigma's Earnings Outlook Strengthens Ahead of Merger -- Market Talk
2215 GMT - Citi raises its earnings forecasts for Sigma Pharmaceuticals ahead of its merger with Australia's Chemist Warehouse pharmacy chain. Analyst Mathieu Chevrier increases his Ebit forecast for
Sigma May Wait Longer for Maiden Chemist Warehouse Contribution -- Market Talk
2152 GMT - Morgans no longer expects the Chemist Warehouse business to contribute six months' earnings to Sigma Healthcare in FY 2025, following comments by Sigma around the merger's progress. Key to
Sigma Healthcare Downgraded to Hold From Add by Morgans
Sigma Healthcare Downgraded to Hold From Add by Morgans
Sigma Healthcare Price Target Raised 13% to A$1.30/Share by Citi
Sigma Healthcare Price Target Raised 13% to A$1.30/Share by Citi
Morgans Financial Downgrades Sigma Healthcare to Hold From Add; Price Target Is AU$1.14
Sigma Healthcare (ASX:SIG) has an average rating of hold and price targets ranging from AU$0.78 to AU$1.30, according to analysts polled by CapitalIQ. Price (AUD): $1.23, Change: $+0.01, Percent Chang
Sigma Healthcare Posts Higher Profit, Lower Sales Revenue in FY24
Sigma Healthcare's (ASX:SIG) net profit attributable to shareholders rose 149% to AU$4.5 million in the year ended Jan. 31, from AU$1.8 million a year ago, according to a Thursday filing with the Aust
Chemist Warehouse Merger Target Sigma Reports 149% FY24 Profit Jump
The market may be charging higher today, but the same cannot be said for the Sigma Healthcare Ltd (ASX: SIG) share price.
Sigma Healthcare: Final Dividend 0.5 Australian Cent
Sigma Healthcare: Final Dividend 0.5 Australian Cent
Sigma Healthcare: Reaffirms Medium-Term Ebit Target of 1.5%-2.5% on Standalone Basis
Sigma Healthcare: Reaffirms Medium-Term Ebit Target of 1.5%-2.5% on Standalone Basis
Sigma Healthcare: Year-to-Date Sales Up 6.6%, Momentum Remains Positive
Sigma Healthcare: Year-to-Date Sales Up 6.6%, Momentum Remains Positive
Sigma Healthcare: Lower Net Revenue Reflects Disposal of Hospital Distribution Business, Past Sales of Rapid Antigen Tests
Sigma Healthcare: Lower Net Revenue Reflects Disposal of Hospital Distribution Business, Past Sales of Rapid Antigen Tests
Sigma Healthcare: FY Net Profit Attrib to Owners A$4.5 Mln, Up 149%
Sigma Healthcare: FY Net Profit Attrib to Owners A$4.5 Mln, Up 149%
Barrenjoey Starts Sigma Healthcare at Overweight With AU$1.30 Price Target
03:10 AM EST, 03/05/2024 (MT Newswires) -- Barrenjoey Starts Sigma Healthcare at Overweight With AU$1.30 Price Target Price (AUD): $1.15, Change: $0.00, Percent Change: 0.00%
Sigma Healthcare Price Target Raised 47% to A$1.15/Share by Citi
Sigma Healthcare Price Target Raised 47% to A$1.15/Share by Citi
No Data